文献速递妇科生殖医学

IA期和IC期上皮性卵巢癌保留生育功能手术后的全因死亡率和癌症特异性死亡率

All-cause and cancer-specific mortality after fertility-sparing surgery for stage IA and IC epithelial ovarian cancer.
PubMed 文献 · Gynecol Oncol · 2023-10-04

研究比较2000至2015年加州癌症登记中18-45岁IA或IC期上皮性卵巢癌患者接受保留生育功能手术(FSS)与标准手术后的全因和癌症特异性死亡率,共1119例,390例(34.9%)接受FSS。FSS与全因死亡率(HR 1.04,95%CI 0.72-1.49)或癌症特异性死亡率(HR 1.50,95%CI 0.97-2.31)增加无关。

要点

  • FSS未增加全因死亡率(HR 1.04,95%CI 0.72-1.49)。
  • FSS未增加癌症特异性死亡率(HR 1.50,95%CI 0.97-2.31)。
  • 10年全因生存概率FSS组85.4% vs 标准手术组86.4%。

核心结论

  • 在生殖年龄早期上皮性卵巢癌患者中,保留生育功能手术与标准手术相比未与死亡风险增加相关。

研究设计与样本

  • 基于加州癌症登记(2000-2015年)的队列研究,纳入18-45岁IA或IC期上皮性卵巢癌患者1119例,其中390例(34.9%)接受FSS。
  • FSS定义为保留对侧卵巢和子宫,标准手术至少包括切除双侧卵巢和子宫。
  • 采用逆概率治疗加权(IPTW)平衡协变量,生成FSS组394例和标准手术组723例的平衡队列,用Kaplan-Meier法和Cox比例风险分析建模生存结局。

主要发现

  • FSS组有45例死亡,10年全因生存概率85.4%(95%CI 0.79-0.92);标准手术组有81例死亡,10年全因生存概率86.4%(95%CI 0.83-0.90)。
  • FSS与全因死亡率增加无关(HR 1.04,95%CI 0.72-1.49)。
  • FSS与癌症特异性死亡率增加无关(HR 1.50,95%CI 0.97-2.31)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare all-cause and cancer-specific mortality between women who underwent fertility-sparing surgery (FSS) versus standard surgery for stage IA and IC epithelial ovarian cancer. METHODS: Reproductive aged patients (18-45) with stage IA or IC epithelial ovarian cancer diagnosed between 2000 and 2015 were identified in the California Cancer Registry. FSS was defined as retention of the contralateral ovary and the uterus, and standard surgery included at least removal of both ovaries and the uterus. The primary outcome was all-cause mortality and the secondary outcome was cancer-specific mortality. Inverse probability of treatment weighting (IPTW) was used to create two groups balanced on covariates of interest. The Kaplan-Meier method and Cox proportional hazards analysis were used to model survival outcomes. RESULTS: Among 1119 women who met inclusion criteria, 390 (34.9%) underwent FSS. IPTW yielded a balanced cohort of 394 women who underwent FSS and 723 women who underwent standard surgery. Among patients who underwent FSS, there were 45 deaths corresponding to an 85.4% (95% confidence interval [CI] 0.79-0.92) 10-year all-cause survival probability, compared to 81 deaths and 86.4% 10-year all-cause survival probability (95% CI 0.83-0.90) among patients who underwent standard surgery. FSS was not associated with increased all-cause mortality (HR 1.04, 95% CI 0.72-1.49) or cancer-specific mortality (HR 1.50, 95%CI 0.97-2.31). CONCLUSIONS: Among reproductive-aged patients with early-stage epithelial ovarian cancer fertility-sparing surgery was not associated with an increased risk of death compared to standard surgery.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Jorgensen K, Denham C, Kanbergs A, et al. All-cause and cancer-specific mortality after fertility-sparing surgery for stage IA and IC epithelial ovarian cancer. Gynecol Oncol. 2023. PMID: 37801736. doi:10.1016/j.ygyno.2023.09.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。